European Alliance for
Newborn Screening in Spinal Muscular Atrophy

Opening a new horizon
for children born with spinal muscular atrophy

SMA: Screen at birth, save lives

Identifying children living with SMA through newborn screening allows for treatment to be started on time, preventing motor neuron death and a life with severe disability or even death.

Learn more about newborn screening for SMA in Europe

Find out more about the status of SMA screening in different countries


Download the latest versions of the SMA NBS Alliance materials

Latest News

EURORDIS Rare On Air Podcast: Newborn screening is key to longer, healthier lives

Listen to the latest episode of EURORDIS’ new podcast on newborn screening featuring Kirsten Johnson, chair of both the Fragile X Society in the UK and Fragile X International, and Gulcin Gumus, Research and Policy Project Manager at EURORDIS.

Newborn screening toolkit for patient advocacy groups

Listen to the webinar SMA Europe organised on the new NBS patient advocacy toolkit Download the toolkit

SMA NBS Alliance Annual Report 2022

Published 15 December 2022 Overall situation SMA NBS progress and status in 2022 For sources on these updates, please visit and select the country: As newborn screening for SMA is evolving quickly in 2022, if you have an update or correction, you can share it with the Alliance via the Secretariat at: [email protected] SMA […]

The European Alliance for Newborn Screening in Spinal Muscular Atrophy demands that by 2025, newborn screening programmes in all European countries include a test for spinal muscular atrophy for all newborn children.